Posted in | News | Copper | Silver | Molybdenum

Bard Ventures Proclaims Phase I Initial Exploration Results from Lone Pine Property

Bard Ventures has received the 2011 phase I primary drilling results from its Lone Pine property. The results of the drill hole BD-11-67 has shown the high-grade mineralization persisting through the drill hole intercept regions that are extensively spaced. The property is located in the Omineca Mining Division and is 15 km to the northwest-north direction of Houston in BC.

The company has got and inferred the assay results of the primary drill core, which was completed in its 2011 phase I drilling program at the property. BD-11-67 is the initial drill hole of the field season of 2011 and is situated in the Alaskite Zone, which is in the broadly spaced intercept regions. The company’s intersection of high-grade mineralization found near the surface will improve the financial background of the open pit mining. When the assays are obtained and inferred, the results of further drill holes will be announced.

Bard Ventures has cut hornfels volcanics to a depth of 41.7 m vertically at the drill hole BD-11-67. It has intersected the quartz stockwork and Alaskite intrusive, which houses the mineralization of copper and molybdenum, at a depth of 687.1 m vertically. The drill hole ended at a depth of 736.4 m finally in the Quartz Feldspar granite intrusive.

Vancouver-based Acme Analytical Laboratories tested the drill core samples by means of the Group 1E analysis. Analytical methods include a 31 element ICP analysis and then assaying for any molybdenum ICP analysis for more than 4000 ppm of molybdenum

The perfect operation site is present in the property, which contains natural gas pipeline, highway 16, major hydro power transformer substation and transmission line and is 15 kms away from the CN rail line. Under the option agreement the company is presently earning a 100% interest in the property.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 18). Bard Ventures Proclaims Phase I Initial Exploration Results from Lone Pine Property. AZoMining. Retrieved on November 22, 2024 from https://www.azomining.com/News.aspx?newsID=4892.

  • MLA

    Scanlon, Joel. "Bard Ventures Proclaims Phase I Initial Exploration Results from Lone Pine Property". AZoMining. 22 November 2024. <https://www.azomining.com/News.aspx?newsID=4892>.

  • Chicago

    Scanlon, Joel. "Bard Ventures Proclaims Phase I Initial Exploration Results from Lone Pine Property". AZoMining. https://www.azomining.com/News.aspx?newsID=4892. (accessed November 22, 2024).

  • Harvard

    Scanlon, Joel. 2019. Bard Ventures Proclaims Phase I Initial Exploration Results from Lone Pine Property. AZoMining, viewed 22 November 2024, https://www.azomining.com/News.aspx?newsID=4892.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.